NASDAQ:TCMD

Tactile Systems Technology Stock News

etoro logo Buy TCMD
*Your capital is at risk
$26.43
+0.0700 (+0.266%)
At Close: Jun 16, 2026
TCMD's Nimbl pneumatic compression system gets CMS PDAC approval and is set to be launched in the United States soon, following FDA clearance for treating lymphedema.
The average of price targets set by Wall Street analysts indicates a potential upside of 57.3% in Tactile Systems Technology (TCMD). While the effectiveness of this highly sought-after metric is quest
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
After reaching an important support level, Tactile Systems Technology (TCMD) could be a good stock pick from a technical perspective. TCMD surpassed resistance at the 20-day moving average, suggesting
After reaching an important support level, Tactile Systems Technology (TCMD) could be a good stock pick from a technical perspective. TCMD surpassed resistance at the 50-day moving average, suggesting
Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Ch
Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.05 per share a year ago.
MINNEAPOLIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people w
MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people w
The medical field is a non-negotiable aspect of society. Advanced healthcare is required to combat existing diseases and protect ourselves from new ones.
MINNEAPOLIS, May 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people wi
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2024 Earnings Conference Call May 6, 2024 5:00 PM ET Company Participants Sam Bentzinger – Investor Relations-Gilmartin Group LLC Dan Reuvers – P
Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.03 per share a year ago.
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people wi
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE